{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T17:56:24Z","timestamp":1720634184977},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.gastrohep.2014.05.008","type":"journal-article","created":{"date-parts":[[2014,9,7]],"date-time":"2014-09-07T08:22:07Z","timestamp":1410078127000},"page":"1-6","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Reactivaci\u00f3n del virus de la hepatitis B en pacientes tratados con rituximab: incidencia y factores de riesgo"],"prefix":"10.1016","volume":"38","author":[{"given":"Mar\u00eda Luisa","family":"Guti\u00e9rrez Garc\u00eda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Alonso Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Dolores","family":"Mart\u00edn Rios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Sanmartin Fenollera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Agudo Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Conrado Manuel","family":"Fern\u00e1ndez Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gastrohep.2014.05.008_bib0005","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/1096-9071(200011)62:3<299::AID-JMV1>3.0.CO;2-0","article-title":"Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: A prospective study of 626 patients with identification of risk factors","volume":"62","author":"Yeo","year":"2000","journal-title":"J Med Virol"},{"key":"10.1016\/j.gastrohep.2014.05.008_bib0010","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/hep.21051","article-title":"Diagnosis, prevention and managemenet of hepatitis B virus reactivation during anticancer therapy","volume":"43","author":"Yeo","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2014.05.008_bib0015","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1182\/blood-2003-05-1403","article-title":"Fatal hepatitis B virus reactivation by an escape mutant following rituximab therapy","volume":"102","author":"Westhoff","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.gastrohep.2014.05.008_bib0020","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1200\/JCO.1999.17.1.268","article-title":"Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy","volume":"17","author":"Czuczman","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gastrohep.2014.05.008_bib0025","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1056\/NEJM200101043440120","article-title":"Acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was receiving rituximab","volume":"344","author":"Dervite","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gastrohep.2014.05.008_bib0030","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1038\/sj.leu.2403914","article-title":"Fulminant B hepatitis in a surface antigen-negative patient with B-cell chronic lymphocytic leukaemia after rituximab therapy","volume":"19","author":"Niscola","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.gastrohep.2014.05.008_bib0035","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10156-005-0385-Z","article-title":"HBV reactivation with fatal fulminating hepatitis during rituximab treatment in a subject negative for HBsAg and positive for HBsAb and HBcAb","volume":"11","author":"Sarrecchia","year":"2005","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.gastrohep.2014.05.008_bib0040","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1080\/10428190500062932","article-title":"Fatal reactivation of hepatitis B post-chemotherapy for lymphoma in a hepatitis B surface antigen-negative, hepatitis B core antibody-positive patient: Potencial implications for future prophylaxis recommendations","volume":"46","author":"Law","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.gastrohep.2014.05.008_bib0045","doi-asserted-by":"crossref","first-page":"721","DOI":"10.2169\/internalmedicine.45.1590","article-title":"Anti-HBs-positive liver failure due to hepatitis B virus reactivation induced by rituximab","volume":"45","author":"Sera","year":"2006","journal-title":"Intern Med"},{"key":"10.1016\/j.gastrohep.2014.05.008_bib0050","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/ajh.20540","article-title":"Fulminant hepatitis B following rituximab therapy in a patient with Evans syndrome and large B-cell lymphoma","volume":"81","author":"Ozgonenel","year":"2006","journal-title":"Am J Hematol"},{"key":"10.1016\/j.gastrohep.2014.05.008_bib0055","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1080\/10428190601059704","article-title":"Fulminant B hepatitis in a surface antigen and hepatitis B DNA-negative patient with diffuse large-B-cell lymphoma after CHOP chemotherapy plus rituximab","volume":"48","author":"Yamagata","year":"2007","journal-title":"LeuK Lymphoma"},{"key":"10.1016\/j.gastrohep.2014.05.008_bib0060","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1365-2141.2008.07318.x","article-title":"Entecavir as a first-line treatment for HBV reactivation following polychemotherapy plus rituximab","volume":"143","author":"Colson","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.gastrohep.2014.05.008_bib0065","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1002\/jmv.21311","article-title":"Molecular characterization of a variant virus that caused de novo hepatitis B without elevation of hepatitis B surface antigen after chemotherapy with ritiximab","volume":"80","author":"Miyagawa","year":"2008","journal-title":"J Med Virol"},{"key":"10.1016\/j.gastrohep.2014.05.008_bib0070","doi-asserted-by":"crossref","first-page":"655","DOI":"10.7326\/0003-4819-150-9-200905050-00024","article-title":"Hepatitis B virus reactivation in a patient with resolved hepatitis B virus infection receiving maintenance rituximab for malignant B cell lymphoma","volume":"150","author":"Koo","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.gastrohep.2014.05.008_bib0075","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s00277-003-0748-4","article-title":"Possible efficacy of lamivudine treatment to prevent hepatitis B virus reactivation due to rituximab therapy in a patient with non-Hodgkin\u2018s lymphoma","volume":"83","author":"Tsutsumi","year":"2004","journal-title":"Ann Hematol"},{"key":"10.1016\/j.gastrohep.2014.05.008_bib0080","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1002\/ajh.20737","article-title":"Fatal postlymphoma chemotherapy hepatitis B reactivation secondary to the emergence of a YMDD mutant strain with lamivudine resistence in a noncirrhotic patient","volume":"81","author":"Law","year":"2006","journal-title":"Am J Hematol"},{"key":"10.1016\/j.gastrohep.2014.05.008_bib0085","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/ajh.20861","article-title":"Hepatitis B virus reactivation in a case of Waldenstro\u1e3fs macroglobulinemia treated with chemotherapy and rituximab despite adefovir prophylaxis","volume":"82","author":"Khaled","year":"2007","journal-title":"Am J Hematol"},{"key":"10.1016\/j.gastrohep.2014.05.008_bib0090","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1177\/030089160809400519","article-title":"Fatal HBV-related liver failure during lamivudine therapy in a patient with non-Hodgkin's lymphoma","volume":"94","author":"Marino","year":"2008","journal-title":"Tumori"},{"key":"10.1016\/j.gastrohep.2014.05.008_bib0095","first-page":"483","article-title":"Fatal acute liver failure due to reactivation of hepatitis B following treatment with fludarabine\/cyclophosphamide\/rituximab for low grade non-Hodgkin's lymphoma","volume":"13","author":"Wasmuth","year":"2008","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.gastrohep.2014.05.008_bib0100","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00431-009-1000-6","article-title":"Fulminant hepatitis B and acute hepatitis B due to intrafamilial transmission of HBV after chemotherapy por non-Hodgkin's lymphoma. In a HBV carrier","volume":"169","author":"Aomatsu","year":"2010","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.gastrohep.2014.05.008_bib0105","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.gastro.2006.04.015","article-title":"Kinetics and risk of the novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy","volume":"131","author":"Hui","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2014.05.008_bib0110","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00277-007-0320-8","article-title":"Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Chinise patients","volume":"86","author":"Li","year":"2007","journal-title":"Ann Hemathol"},{"key":"10.1016\/j.gastrohep.2014.05.008_bib0115","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3324\/haematol.12557","article-title":"Hepatitis B virus-related liver disease in isolated anti-hepatitis B-core positive lymphoma patients receiving chemo-or chemo-immune therapy","volume":"93","author":"Targhetta","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.gastrohep.2014.05.008_bib0120","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1200\/JCO.2008.18.0182","article-title":"Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab","volume":"27","author":"Yeo","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gastrohep.2014.05.008_bib0125","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/ajh.21343","article-title":"Incidence of hepatitis B reactivation following Rituximab therapy","volume":"84","author":"Hanbali","year":"2009","journal-title":"Am J Hematol"},{"key":"10.1016\/j.gastrohep.2014.05.008_bib0130","first-page":"2013","article-title":"Retrospective and prospective studies of hepatitis B virus reactivation in malignant lymphoma with occult HBV carrier","volume":"20","author":"Fukushima","year":"2009","journal-title":"Int J Hematol"},{"key":"10.1016\/j.gastrohep.2014.05.008_bib0135","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s12185-009-0359-5","article-title":"Reactivation of hepatitis B virus following systemic chemotherapy for malignant lymphoma","volume":"90","author":"Kusumoto","year":"2009","journal-title":"Int J Hematol"},{"key":"10.1016\/j.gastrohep.2014.05.008_bib0140","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00277-008-0585-6","article-title":"Analysis of reactivation of hepatitis B in the treatment of B cell non-Hodgkin's lymphoma in Hokkaido","volume":"88","author":"Tsutsumi","year":"2009","journal-title":"Ann Hemathol"},{"key":"10.1016\/j.gastrohep.2014.05.008_bib0215","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1471-2407-8-115","article-title":"Clinical and prognostic analysis of hepatitis B virus infection in diffuse large B-cell lymphoma","volume":"8","author":"Wang","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1016\/j.gastrohep.2014.05.008_bib0150","first-page":"257","article-title":"Serum hepatitis B virus DNA in healthy HBsAg-negative Chinise adults evaluated by polymerase chain reaction","author":"Shin","year":"1990","journal-title":"J Med Virol"},{"key":"10.1016\/j.gastrohep.2014.05.008_bib0155","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1093\/annonc\/mdq583","article-title":"Riruximab-associated hepatitis B reactivation in lymphoproliferative diseases: Meta-analysis and examination of FDA safety reports","volume":"22","author":"Evens","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.gastrohep.2014.05.008_bib0160","doi-asserted-by":"crossref","first-page":"5097","DOI":"10.1200\/JCO.2010.29.7531","article-title":"Prospective analysis of hepatitis B virus reactivation in patients with diffuse large B-cell lymphoma after rituximab combination chemotherapy","volume":"28","author":"Niitsu","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gastrohep.2014.05.008_bib0165","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00277-009-0806-7","article-title":"Reactivation of hepatitis B virus following rituximab-based regimens: A serious complication in both HBsAg-positive and HBsAg-negative patients","volume":"89","author":"Pei","year":"2010","journal-title":"Ann Hematol"},{"key":"10.1016\/j.gastrohep.2014.05.008_bib0170","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s00277-011-1241-0","article-title":"Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative\/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis","volume":"90","author":"Koo","year":"2011","journal-title":"Ann Hematol"},{"key":"10.1016\/j.gastrohep.2014.05.008_bib0175","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00535-010-0331-4","article-title":"Reactivation of hepatitis B virus following rituximab-plus-steroid combination chemotherapy","volume":"46","author":"Kusumoto","year":"2011","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2014.05.008_bib0180","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/sj.bjc.6601699","article-title":"Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy","volume":"90","author":"Yeo","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.gastrohep.2014.05.008_bib0185","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1182\/blood.V99.7.2324","article-title":"High hepatitis B virus (HBV) DNA viral load as the most important risk factor for HBV reactivation in patients positive for HBV surface antigen undergoing autologous hematopoietic cell transplantation","volume":"99","author":"Lau","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.gastrohep.2014.05.008_bib0190","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1053\/jhep.2003.50220","article-title":"Lymphoma Committee of Taiwan Cooperative Oncology Group. Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma","volume":"37","author":"Cheng","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2014.05.008_bib0195","doi-asserted-by":"crossref","first-page":"8726","DOI":"10.1016\/j.vaccine.2007.10.027","article-title":"Declining prevalence of hepatitis B virus infection in Catalonia (Spain) 12 years after the introduction of universal vaccination","volume":"25","author":"Salleras","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.gastrohep.2014.05.008_bib0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.23190","article-title":"Chronic hepatitis B: Update 2009","volume":"50","author":"Lok","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2014.05.008_bib0205","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"E.A.S.L. Clinical Practice Guidelines: management of chronic hepatitis B","volume":"57","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2014.05.008_bib0210","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.gastrohep.2012.04.006","article-title":"Consensus document of the spanish association for the studyof the liver on the treatment of Hepatitis B infection (2012)","volume":"35","author":"Buti","year":"2012","journal-title":"Gastroenterol Hepatol"}],"container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S021057051400171X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S021057051400171X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T15:10:11Z","timestamp":1565795411000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S021057051400171X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S021057051400171X"],"URL":"https:\/\/doi.org\/10.1016\/j.gastrohep.2014.05.008","relation":{},"ISSN":["0210-5705"],"issn-type":[{"value":"0210-5705","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reactivaci\u00f3n del virus de la hepatitis B en pacientes tratados con rituximab: incidencia y factores de riesgo","name":"articletitle","label":"Article Title"},{"value":"Gastroenterolog\u00eda y Hepatolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastrohep.2014.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Espa\u00f1a, S.L.U. and AEEH y AEG. All rights reserved.","name":"copyright","label":"Copyright"}]}}